- Home
- LNTH vs TFSL Comparison
LNTH vs TFSL Comparison
Compare LNTH & TFSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- TFSL
- Stock Information
- Founded
- LNTH 1956
- TFSL 1938
- Country
- LNTH United States
- TFSL United States
- Employees
- LNTH N/A
- TFSL N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- TFSL Savings Institutions
- Sector
- LNTH Health Care
- TFSL Finance
- Exchange
- LNTH Nasdaq
- TFSL Nasdaq
- Market Cap
- LNTH 3.6B
- TFSL 3.9B
- IPO Year
- LNTH 2015
- TFSL 2007
- Fundamental
- Price
- LNTH $52.94
- TFSL $13.37
- Analyst Decision
- LNTH Strong Buy
- TFSL Hold
- Analyst Count
- LNTH 5
- TFSL 1
- Target Price
- LNTH $91.60
- TFSL $15.00
- AVG Volume (30 Days)
- LNTH 1.5M
- TFSL 403.3K
- Earning Date
- LNTH 11-05-2025
- TFSL 10-29-2025
- Dividend Yield
- LNTH N/A
- TFSL 8.45%
- EPS Growth
- LNTH N/A
- TFSL 3.58
- EPS
- LNTH 3.77
- TFSL 0.29
- Revenue
- LNTH $1,520,653,000.00
- TFSL $308,625,000.00
- Revenue This Year
- LNTH N/A
- TFSL $6.24
- Revenue Next Year
- LNTH $3.24
- TFSL $8.69
- P/E Ratio
- LNTH $14.03
- TFSL $46.10
- Revenue Growth
- LNTH 5.75
- TFSL 1.03
- 52 Week Low
- LNTH $47.25
- TFSL $11.29
- 52 Week High
- LNTH $118.21
- TFSL $15.00
- Technical
- Relative Strength Index (RSI)
- LNTH 38.79
- TFSL 47.21
- Support Level
- LNTH $51.94
- TFSL $13.18
- Resistance Level
- LNTH $55.24
- TFSL $13.73
- Average True Range (ATR)
- LNTH 1.97
- TFSL 0.24
- MACD
- LNTH 0.48
- TFSL -0.07
- Stochastic Oscillator
- LNTH 14.89
- TFSL 16.24
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About TFSL TFS Financial Corporation
TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.